These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8635377)

  • 1. Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol.
    Bremner P; Siebers R; Crane J; Beasley R; Burgess C
    Chest; 1996 Apr; 109(4):957-62. PubMed ID: 8635377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
    Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
    Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol.
    Bremner P; Woodman K; Burgess C; Crane J; Purdie G; Pearce N; Beasley R
    Eur Respir J; 1993 Feb; 6(2):204-10. PubMed ID: 8095240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
    Windom H; Grainger J; Burgess C; Crane J; Pearce N; Beasley R
    N Z Med J; 1990 Jun; 103(891):259-61. PubMed ID: 1972557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
    Crane J; Burgess C; Beasley R
    Thorax; 1989 Feb; 44(2):136-40. PubMed ID: 2928998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics.
    Bremner P; Burgess C; Beasley R; Woodman K; Marshall S; Crane J; Pearce N
    Respir Med; 1992 Sep; 86(5):419-23. PubMed ID: 1462021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
    Newnham DM; Wheeldon NM; Lipworth BJ; McDevitt DG
    Thorax; 1993 Jun; 48(6):656-8. PubMed ID: 8102213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma.
    Windom HH; Burgess CD; Siebers RW; Purdie G; Pearce N; Crane J; Beasley R
    Clin Pharmacol Ther; 1990 Sep; 48(3):296-301. PubMed ID: 1976051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extrapulmonary effects of increasing doses of formoterol in patients with asthma.
    Burgess C; Ayson M; Rajasingham S; Crane J; Della Cioppa G; Till MD
    Eur J Clin Pharmacol; 1998 Apr; 54(2):141-7. PubMed ID: 9626918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.
    Scheinin M; Koulu M; Laurikainen E; Allonen H
    Br J Clin Pharmacol; 1987 Nov; 24(5):645-53. PubMed ID: 2829953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-agonistic bronchodilators: comparison of dose/response in working rat hearts.
    Zimmer G; Dahinten A; Fitzner A; Halbig S; Noll T; Treusch F; Libertus H
    Chest; 2000 Feb; 117(2):519-29. PubMed ID: 10669699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects.
    Bennett JA; Harrison TW; Tattersfield AE
    Eur Respir J; 1999 Feb; 13(2):445-8. PubMed ID: 10065696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.
    Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG
    Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma.
    Newhouse MT; Dolovich MB; Kazim F
    Chest; 1994 Jun; 105(6):1738-42. PubMed ID: 8205869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of high doses of broncholytics on the state of cardiovascular system during treatment of sever exacerbation of bronchial asthma].
    Makolkin VI; Ovcharenko SI; Peredel'skaia OA; Axel'rod AS
    Kardiologiia; 2004; 44(2):65-9. PubMed ID: 15125428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response of inhaled drugs in asthma. An update.
    Clark DJ; Lipworth BJ
    Clin Pharmacokinet; 1997 Jan; 32(1):58-74. PubMed ID: 9012556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.